Olendalizumab
Product Specifications
CAS Number
2210314-30-8
Target
Complement System
Related Pathways
Immunology/Inflammation
Bioactivity
Olendalizumab (ALXN1007), a humanized IgG2-G4-κ antibody derived from mice, specifically targets Complement protein C5a with a binding affinity (K i) of 60 pM. This compound is designed to inhibit the complement inflammatory pathway. Additionally, olendalizumab is utilized in the research of complement-mediated disorders triggered by the coronavirus [1] [2].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS010384-100ug 100 µg
BTN3A3 (NM_006994) Human Over-expression Lysate
Sign In for Pricing
View Details MBS1053493-01 0.02 mg (E-Coli)
Recombinant Mycobacterium bovis Uncharacterized protein Mb2339 (Mb2339)
Sign In for Pricing
View Details